ArticleScientific reports2019

Inhibition of tumour necrosis factor alpha in the R6/2 mouse model of Huntington's disease by etanercept treatment.

Jeffrey Pido-Lopez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.